Ralph Schiess
Chief Executive Officer at ONCONETIX, INC.
Net worth: 41 541 $ as of 2024-03-30
Profile
Ralph Schiess is the founder and Chief Executive Officer of Proteomedix AG, a company founded in 2010.
He is currently the Chief Executive & Science Officer at Onconetix, Inc., a position he started in 2023.
Dr. Schiess has a graduate degree from the University of Zurich and a doctorate degree from the Swiss Federal Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ONCONETIX INC
1.21% | 2024-04-04 | 269,749 ( 1.21% ) | 41 541 $ | 2024-03-30 |
Ralph Schiess active positions
| Companies | Position | Start |
|---|---|---|
| ONCONETIX, INC. | Chief Executive Officer | 2024-01-11 |
ProteoMediX AG
 ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Chief Executive Officer | 2009-12-31 |
Training of Ralph Schiess
| University of Zurich | Graduate Degree |
| Swiss Federal Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ONCONETIX, INC. | Health Technology |
| Private companies | 1 |
|---|---|
ProteoMediX AG
ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Ralph Schiess
